We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA issued a warning that active pharmaceutical ingredient baclofen manufactured by Taizhou Xinyou Pharmaceutical & Co. Limited, may be at risk for contamination and should not be used to compound sterile injectable drugs. Read More
Indian analysts attribute ongoing quality control issues with pharmaceutical exports to a dearth of pharmaceutical inspectors and a lack of uniform standards in the country. Read More
With an eye toward rare-disease research, the Biotechnology Industry Organization and a Duchenne patient advocacy group are joining forces to help drugmakers design clinical studies with patient input. Read More
A drug wholesaler has been indicted for allegedly defrauding pharmacies to the tune of $100 million by selling them second-hand prescription medications obtained through the black market. Read More
The FDA’s Office of Regulatory Affairs is making progress on its new program alignment and released information on what the new structure will look like. Read More
With such a strong unmet need in severe asthma patients and convincing evidence of improvement in this population, Teva Pharmaceuticals’ candidate reslizumab warrants approval, FDA advisors said Wednesday. Read More